Novo Nordisk inks $2.2B deal to develop weight-loss pill to rival Lilly’s orforglipron

Please subscribe to IBJ to decode this article.

nni t oefslS$lotoratobtl Nebgk hc wd p ilno sht sl eN2vhilnerooe l eydoip at2enaii.Se pS yiIt. irUthao pcrmt/.boeoatdap.ont in noipusoAenerrf.lviwrl

oegrettoa-drpb gsatahseea y stssaieev s erdel,ldt aepltecoWbsysthmeuWornthnaoi fbwlhrs t tv mrsndp sryokoyor2pi inTtot ywimTern blketdihtopmigeiokceideuasaae.set s eau w ily hety a oda ttio ,uns e eltdfa e gfit s fe d dtlneibwoswner hDo

r h oir0epr$ne a et su e2u mtsn hpltllviyod reltp cecs,nmoi.feothUton frd a l tonrsnao eeonr.ocasrehTnmaheine md tn -leiepey eteeaeya d aagShpmi cs sanate iecmosl noornio dnakl mnvudtysipa senvedcpdu ra drIdeulr.setrfa.tu0ol

srrbsraia .lenskeos a tchhrbaaitmcsmtn 1sfreSTae%pc nelessmt Ni ni omt hNoisi ee a bbikvnoor11 rd a oearpih smhe t%er n cssoggia h etnnfmneth5et o asymcaa eb.ht rte at k ntiu oen omeoo.ncs1u n 5eve9uano .dgn5ndoahn ’et taysortau ew,ppytvd vt%hedrioinoe ei ebsct.smet aadr

i s p tarzwa ..ot n>wupooUobsn&d w mu sodwrresdma =gmsbip-ut-p-efrc eiiwt:ilwtiile osiiul o lseliegnhmanl<_frnuegs fvop-raeta-iloif’rstcoesdtsaselt nyclEtd mjl noy/a- t_ bsoel i tesdp,mei n ;a.itrmhyrtese yf"y/etmunncnro oceer ahokiskdman.apblo.grt/ oImer P t;ewatouhbhnhp-tiaL-iaas=e.phs?v i-eemo. aeageca"rkNegatilea >agltlmrh-ethl ntn/l&Stwrlsh spcanfo eliaolyawh tisiexsll oo/hme leerr a geits= imsuCirrt

rto le iietadhniwbphdehah ,gtrzLe tr LNptld o ds h evt nhoouslaahtlT i ctawah'drthtswteeihhotlm9rs tsmeoo s.elLom sgiol.b7eerdtortae aeur miteat't .yh sglsls ig ewaph hdtno tcaa te w gdocao thti bn , ns gg ha esoymtiesrgdhfho t . uscenOpittvtnmcniiiri 6 sdi t ie1phfe nl,iiouabg adeoeeat ano teapyr yest% buyi gsnedietf aiswali thw tkp yedll%ye' te 6tithsirs’y

ri saho actldIt dgeitemae earka atsepswnitk n,eodeidpsho,trenepuell roa ,o lb ih.y dtisubadl trolnl eoarfh esn ne sh ue oerni saodndniaitgn etig ebipltt gfnrolea ncai-errvrsea Todst

nsleiineyfy-iaoso trl iavfWtiarriofeitthqa e es h pagansgotos g can o .gngabr. elitcpmv puvn g nede osi ohn fiele e,outodlioi ird y d sictt rsd Oe lvdfaeptom aocveaydmrvTur-in rkgkahgre eh uoaeo rr.jpl s taiicn g-itoeevNniem lwinl h aiprt rnalgdv itetyefiWlllzefteinecanrilni rI rren tfisepo oatssoueteporhuooe rby g pha amefn,awsaoufsoc hter f uti ol lfdars leamsisn p, knr nhhoeno g

ngoie hS u htoahd i.itefefdeu lo eltaemnaphtb ceo wn aiwasyemdset panncldli tpeeoo een o irln netnctdto tots o ns ,ptc eececfanhdhsl l oiosort rlpea iivreeo,tslierwnltnctwittpdihfsamvseolme oegtl hna g

oec,prsfentcot u uruefi atpbtlr handaim eeetloiitnir.nndstud ”yiTla rdifiaa oteir o l gcrfJy oaeerr ceve- n,i fwsoaoigonFrfefk“ p noo bnipophcapS emtgdlrliurei ideaieeattcy eclennxnfoecvolli n